Clinical Trial

The Use of a Porcine Collagen Matrix for the Prevention of Buccal Bone Wall Resorption During Implant Placement in the Aesthetic Zone.

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated August 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Aim: To provide a comparative assessment of the clinical and radiographic effect of porcine collagen matrix when placed buccally at the time of single implant placement in the aesthetic zone vs autogenous connective tissue graft in terms of buccal bone resorption and soft tissue augmentation 6 months post operative. Histological assessment and patient reported outcomes were reported
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-29.
Trial Details
NCT Number NCT06622759
Lead Sponsor Aristotle University Of Thessaloniki
Conditions Soft Tissue Augmentation
Enrollment 36 participants
Start Date 2023-03-24
Primary Completion 2025-08-20 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-07